SCHEDULE OF CUMULATIVE WARRANT ACTIVITY (Details) - Warrant [Member] - $ / shares |
9 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2025 |
Sep. 30, 2024 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
| Number of warrant shares, outstanding, beginning | 817,864 | |
| Weighted average exercise price per share, outstanding, beginning | $ 17.28 | |
| Number of shares warrants issued | 3,717,648 | 881,639 |
| Weighted average exercise price per share, issued | $ 23.05 | $ 17.48 |
| Weighted average contractual term (in years), outstanding, warrant issued | 5 years | 5 years |
| Number of shares warrants exercised | (1,248,158) | (63,775) |
| Weighted average exercise price per share, exercised | $ 16.83 | $ 20.00 |
| Weighted average contractual term (in years), outstanding | 4 years 4 months 13 days | 4 years 9 months 14 days |
| Number of warrant shares, outstanding, ending | 3,287,354 | 817,864 |
| Weighted average exercise price per share, outstanding, ending | $ 24.07 | $ 17.28 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average remaining contractual terms granted. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price per share, outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price per share, warrants exercised. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price per share, warrants issued. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|